anonymous
Guest
anonymous
Guest
It will be interesting to see. I'm not convinced that the future of robotic surgery can sustain multiple platforms. MDT and Verb probably based their revenue models on ISI, the problem being that hospitals are currently losing their collective asses on the inflated cost of robotic procedures. The market will eventually correct, and when it does, robotic surgery will be far less profitable for OEMs in the space.
More players = more competitions = more innovations and hopefully it will lead to lower price???